Survey

Serving To Educate Primary Care Clinicians On Metabolic Issues

Evidence Based Medicine Header 1

Medical Education Header 2

Metabolic Diseases Header 4

ADA Obesity Three

I am a(n)…

Select...

How many years have you been in practice?

Select...

What is your practice setting?

Select...

Number of patients seen per month with obesity

Select...

Please rate the following:

Degree to which your educational expectations were met

Select...

Relevance to your practice

Select...

Effective faculty presenter

Select...

Overall Presentation

Select...

Please rate the degree to which the Learning Objective was met.

Individualize patient care based on knowledge of pharmacologic treatment

Select...

Agree or Disagree?

The presentation was fair and balanced, free of commercial bias.

Select...

I feel more competent as a result of the presentation.

Select...

The presentation was scientifically rigorous.

Select...

The content contributed valuable information that will assist in improving patient outcomes

Select...

Will you change your practice behaviors as a result of the presentation?

Select...

What will you change?

If Other

What barriers to change do you foresee?

If Other

What was your level of knowledge on this subject?

Before the presentation

Select...

After the presentation

Select...

True or False? Anti-obesity pharmacologic therapy is indicated for BMI = 30 kg/m2 or BMI = 27 30 kg/m2 with obesity-related comorbidities.

True or False? Lifestyle changes are unnecessary when pharmacologic treatments are used.

How confident do you feel in your answer to the previous question?

Select...